CH552606A - Verfahren zur herstellung von 5-azapyrimidinnucleosiden. - Google Patents

Verfahren zur herstellung von 5-azapyrimidinnucleosiden.

Info

Publication number
CH552606A
CH552606A CH352271A CH352271A CH552606A CH 552606 A CH552606 A CH 552606A CH 352271 A CH352271 A CH 352271A CH 352271 A CH352271 A CH 352271A CH 552606 A CH552606 A CH 552606A
Authority
CH
Switzerland
Prior art keywords
preparing
azapyrimidine
nucleosides
azapyrimidine nucleosides
Prior art date
Application number
CH352271A
Other languages
German (de)
English (en)
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of CH552606A publication Critical patent/CH552606A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/12—Triazine radicals
CH352271A 1970-03-14 1971-03-10 Verfahren zur herstellung von 5-azapyrimidinnucleosiden. CH552606A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2012888A DE2012888C3 (de) 1970-03-14 1970-03-14 Verfahren zur Herstellung von 5-Azapyrimidinnucleosiden

Publications (1)

Publication Number Publication Date
CH552606A true CH552606A (de) 1974-08-15

Family

ID=5765475

Family Applications (1)

Application Number Title Priority Date Filing Date
CH352271A CH552606A (de) 1970-03-14 1971-03-10 Verfahren zur herstellung von 5-azapyrimidinnucleosiden.

Country Status (19)

Country Link
US (1) US3817980A (sv)
JP (1) JPS5527077B1 (sv)
AT (1) AT313481B (sv)
BE (1) BE764179A (sv)
CA (1) CA946379A (sv)
CH (1) CH552606A (sv)
CS (1) CS162741B2 (sv)
DE (1) DE2012888C3 (sv)
DK (1) DK152134C (sv)
ES (1) ES388193A1 (sv)
FI (1) FI56018C (sv)
FR (1) FR2085707B1 (sv)
GB (1) GB1351003A (sv)
HU (1) HU164144B (sv)
IL (1) IL36363A (sv)
NL (1) NL180835C (sv)
PL (1) PL81543B1 (sv)
SE (1) SE405253B (sv)
ZA (1) ZA711084B (sv)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1531469A (en) * 1975-12-18 1978-11-08 Farmaceutici Italia Daunosamine nucleosides
US4171431A (en) * 1976-08-19 1979-10-16 The Upjohn Company Nucleosides and process
DE2721466A1 (de) * 1977-05-12 1978-11-16 Robugen Gmbh Verfahren zur herstellung von 2'-desoxyribofuranosylnucleosiden
DE2757365A1 (de) * 1977-12-20 1979-06-21 Schering Ag Neues verfahren zur herstellung von nucleosiden
GB1601020A (en) 1978-04-24 1981-10-21 Stichting Grega Vzw 2'-deoxy-5 (2-halogenovinyl)-uridines
US4423212A (en) * 1980-12-18 1983-12-27 The Upjohn Company Nucleosides and process
US5099010A (en) * 1983-01-17 1992-03-24 Research Corporation Intermediates in the preparation of 3'-amino-2',3'-dideoxycytidine and the pharmacologically acceptable salts thereof
JPS60193997A (ja) * 1984-03-14 1985-10-02 Sumitomo Chem Co Ltd 新規シアノイミダゾ−ルリボヌクレオシド誘導体およびその製造法
US4730512A (en) * 1984-10-23 1988-03-15 Toyota Jidosha Kabushiki Kaisha Engine crankshaft structure
CA1301166C (en) * 1987-07-21 1992-05-19 John Nicholas Freskos Process for preparing 2-deoxynucleosides
US6982253B2 (en) * 2002-06-05 2006-01-03 Supergen, Inc. Liquid formulation of decitabine and use of the same
AU2003278904A1 (en) * 2002-09-24 2004-04-19 Kornis Pharmaceuticals, Incorporated 1, 3, 5-triazines for treatment of viral diseases
US6943249B2 (en) * 2003-03-17 2005-09-13 Ash Stevens, Inc. Methods for isolating crystalline Form I of 5-azacytidine
US7038038B2 (en) 2003-03-17 2006-05-02 Pharmion Corporation Synthesis of 5-azacytidine
AU2013200662B2 (en) * 2003-03-17 2015-04-02 Celgene International Sarl Methods for isolating crystalline Form I of 5-azacytidine
AU2012209018B2 (en) * 2003-03-17 2015-04-02 Celgene International Sarl Methods for isolating crystalline Form I of 5-azacytidine
US6887855B2 (en) * 2003-03-17 2005-05-03 Pharmion Corporation Forms of 5-azacytidine
US20060014949A1 (en) * 2004-07-13 2006-01-19 Supergen Inc. Compositions and formulations of decitabine polymorphs and methods of use thereof
US20060128653A1 (en) * 2004-12-10 2006-06-15 Chunlin Tang Pharmaceutical formulation of decitabine
US20060128654A1 (en) * 2004-12-10 2006-06-15 Chunlin Tang Pharmaceutical formulation of cytidine analogs and derivatives
EP2205073A4 (en) * 2007-09-26 2013-03-06 Sinai School Medicine AZACYTIDINE ANALOGS AND USES THEREOF
EP2048151A1 (en) * 2007-10-10 2009-04-15 Cilag AG Method for producing nucleosides by direct glycosylation of the nucleoside base
EP2050757A1 (en) * 2007-10-10 2009-04-22 Cilag AG Method of producing 2' -deoxy-5-azacytidine (Decitabine)
PL3782612T3 (pl) * 2008-05-15 2024-03-04 Celgene Corporation Doustne formulacje analogów cytydyny i sposoby ich zastosowania
WO2010014883A2 (en) 2008-08-01 2010-02-04 Dr. Reddy's Laboratories Ltd. Azacitidine process and polymorphs
WO2010017374A1 (en) * 2008-08-06 2010-02-11 Sicor Inc. Process for preparing azacytidine intermediate
AU2009279461B2 (en) 2008-08-08 2014-01-23 Scinopharm Taiwan, Ltd. Process for making 5-azacytosine nucleosides and their derivatives
MX2011009989A (es) * 2009-03-23 2011-10-14 Ambit Biosciences Corp Metodos de tratamiento utilizando terapia de combinacion.
US20100249394A1 (en) * 2009-03-26 2010-09-30 Albemarle Corporation Processes for producing decitabine
IT1399195B1 (it) 2010-03-30 2013-04-11 Chemi Spa Processo per la sintesi di azacitidina e decitabina
RU2013148580A (ru) 2011-03-31 2015-05-10 Селджин Интернешнл Сарл Синтез 5-азацитидина
AU2013243873B2 (en) 2012-04-04 2016-08-25 Halozyme, Inc. Combination therapy with an anti - hyaluronan agent and a tumor - targeted taxane
CN103884809B (zh) * 2013-08-28 2016-01-27 鲁南制药集团股份有限公司 一种地西他滨中间体的分析检测方法
JP6162349B1 (ja) * 2016-04-21 2017-07-12 大原薬品工業株式会社 ５−アザシチジン類の糖部シリルエーテル誘導体
CN108226309B (zh) 2016-12-13 2020-06-16 江苏奥赛康药业有限公司 一种右丙亚胺的分析方法
CN108239128B (zh) * 2016-12-23 2019-03-29 江苏奥赛康药业股份有限公司 β-核苷类化合物的制备方法
CN110128485B (zh) * 2018-02-09 2022-06-07 鲁南制药集团股份有限公司 一种阿扎胞苷的制备方法
US20190351031A1 (en) 2018-05-16 2019-11-21 Halozyme, Inc. Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1244790B (de) * 1963-10-29 1967-07-20 Ceskoslovenska Akademie Ved Verfahren zur Herstellung des cancerostatisch wirksamen 5-Azacytidins
GB1050899A (sv) * 1963-12-22
US3328388A (en) * 1964-09-02 1967-06-27 Merck & Co Inc Arabinofuranosyl pyrimidines and methods of preparing same
US3346561A (en) * 1965-10-24 1967-10-10 Merck & Co Inc Pyrimidine 3-deoxynucleosides
US3531464A (en) * 1966-10-21 1970-09-29 Us Health Education & Welfare Alternative synthesis of 2'-deoxy-5-(trifluoromethyl)-uridine and the alphaanomer thereof
CH527207A (de) * 1968-05-08 1972-08-31 Ceskoslovenska Akademie Ved Verfahren zur Herstellung von 1-Glycosyl-5-azacytosinen
CH507969A (de) * 1968-11-12 1971-05-31 Ceskoslovenska Akademie Ved Verfahren zur Herstellung von 1-Glycosyl-5-azacytosinen
CH532062A (de) * 1968-11-13 1972-12-31 Ceskoslovenska Akademie Ved Verfahren zur Herstellung von 1-Glykosyl-5-azacytosinen

Also Published As

Publication number Publication date
NL7103459A (sv) 1971-09-16
GB1351003A (en) 1974-04-24
BE764179A (fr) 1971-09-13
IL36363A (en) 1974-05-16
FI56018C (fi) 1979-11-12
PL81543B1 (sv) 1975-08-30
SU374828A3 (sv) 1973-03-20
ZA711084B (en) 1971-10-27
HU164144B (sv) 1973-12-28
NL180835B (nl) 1986-12-01
DK152134C (da) 1988-08-01
DK152134B (da) 1988-02-01
NL180835C (nl) 1987-05-04
IL36363A0 (en) 1971-05-26
DE2012888A1 (de) 1971-09-30
CA946379A (en) 1974-04-30
US3817980A (en) 1974-06-18
FR2085707B1 (sv) 1975-04-18
DE2012888B2 (de) 1980-07-10
AT313481B (de) 1974-02-25
FR2085707A1 (sv) 1971-12-31
CS162741B2 (sv) 1975-07-15
ES388193A1 (es) 1973-05-01
JPS5527077B1 (sv) 1980-07-17
FI56018B (fi) 1979-07-31
SE405253B (sv) 1978-11-27
DE2012888C3 (de) 1981-04-02

Similar Documents

Publication Publication Date Title
CH552606A (de) Verfahren zur herstellung von 5-azapyrimidinnucleosiden.
CH549020A (de) Verfahren zur reinigung von lactamen.
CH549408A (de) Verfahren zur herstellung von mikrogranulaten.
CH547819A (de) Verfahren zur herstellung von isothiazolderiavaten.
CH547243A (de) Verfahren zur herstellung von styrylverbindungen.
CH553828A (de) Verfahren zur herstellung von triarylphosphinen.
CH551461A (de) Verfahren zur herstellung von polymeristdispersionen.
CH547805A (de) Verfahren zur reinigung von lactamen.
CH551991A (de) Verfahren zur herstellung von azacarbazolen.
CH556890A (de) Verfahren zur herstellung von anthrachinonverbindungen.
CH553758A (de) Verfahren zur herstellung von azidosulfonylcarbanilaten.
CH555366A (de) Verfahren zur herstellung von 3-aza-a-homo-steroide.
CH557362A (de) Verfahren zur herstellung von l-pyroglutamyl-l-histidyl -l-prolinamid.
CH552614A (de) Verfahren zur herstellung von bistriazolverbindungen.
CH550164A (de) Verfahren zur herstellung von erythromycyl-b-amin.
CH546733A (de) Verfahren zur herstellung von oberflaechenaktiven verbindungen.
CH551946A (de) Verfahren zur herstellung von n-acyldopa-verbindungen.
DE2134251B2 (de) Verfahren zur herstellung von 4-hydroxyphenyl-glycin
CH550128A (de) Verfahren zur herstellung von pent-4-en-1-alen.
CH549094A (de) Verfahren zur herstellung von zeaxanthin.
CH547292A (de) Verfahren zur herstellung von 6-chlorpyridaziniumverbindungen.
CH557798A (de) Verfahren zur herstellung von enaminketonen.
CH558832A (de) Verfahren zur herstellung von tuberactinomycin-n.
CH547788A (de) Verfahren zur herstellung von 19-nor-steroiden.
CH549553A (de) Verfahren zur herstellung von l-dopa.

Legal Events

Date Code Title Description
PL Patent ceased